Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
JEREMY B. HAYDEN Insider Profile
4 Followers
JEREMY B. HAYDEN, General Counsel & VP of BD at Plus Therapeutics, holds 145.09K shares in Sight Sciences (Ticker: SGHT), holds 32.04K shares in Endologix (Ticker: ELGXQ), holds 26.20K shares in Plus Therapeutics (Ticker: PSTV). Most recently, JEREMY B. HAYDEN Sold ― shares of Sight Sciences on Jan 21, 2025 for an estimated value of 19.24K.
JEREMY B. HAYDEN Plus Therapeutics (PSTV)General Counsel & VP of BD
Plus Therapeutics (PSTV)
General Counsel & VP of BD
Ranked #16,799 out of 100,370 Corporate Insiders
Profitable Transactions
6 out of 9 Profitable Transactions
Average Return
+10.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that JEREMY B. HAYDEN holds in companies
Most Profitable Insider Trade
The most profitable trade made by JEREMY B. HAYDEN
JEREMY B. HAYDEN's Trading History
Plus Therapeutics
Sep 03, 2015
General Counsel & VP of BD
Informative Buy
2.87K
$31.41K
Endologix
Oct 07, 2019
―
Uninformative Buy
―
$608.76
Sight Sciences
Jan 21, 2025
CLO
Informative Sell
19.24K
$442.53K
List of latest transactions for each holding click on a transaction to see JEREMY B. HAYDEN's performance on stock
You May Also Like
JEREMY B. HAYDEN insider profile FAQ
What is the percentage of profitable transactions made by JEREMY B. HAYDEN?
The percentage of profitable transactions made by JEREMY B. HAYDEN is 67%.
What is the average return per transaction made by JEREMY B. HAYDEN?
The average return per transaction made by JEREMY B. HAYDEN is 10.40%.
What stocks does JEREMY B. HAYDEN hold?
JEREMY B. HAYDEN holds: PSTV, ELGXQ, SGHT stocks.
What was JEREMY B. HAYDEN’s latest transaction?
JEREMY B. HAYDEN latest transaction was an Informative Sell of $19.24K.
What was JEREMY B. HAYDEN's most profitable transaction?
JEREMY B. HAYDEN’s most profitable transaction was an Informative Sell of SGHT stock on July 3, 2024. The return on the trade was 52.60%.
What is JEREMY B. HAYDEN's role in Plus Therapeutics?
JEREMY B. HAYDEN's role in Plus Therapeutics is General Counsel & VP of BD.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.